Skip to main content

Table 1 Patient and cancer characteristics

From: Clinical outcomes of doxorubicin-eluting CalliSpheres® beads-transarterial chemoembolization for unresectable or recurrent esophageal carcinoma

Characteristics

Values

Sex, male, n (%)

15 (71.4)

Mean age, Range, years

68.7 ± 9.7 (46–86)

History of chemotherapy, n (%)

10 (47.6)

History of esophageal surgery, n (%)

4 (19.0)

Median course of disease, months

9.0 (2.0, 12.0)

Esophageal carcinoma diagnosis

 

 Adenocarcinoma/Squamous cell carcinoma

18 (85.7)/3 (14.3)

 Local/distant metastases

8 (38.1)/3 (14.3)

Comorbidities, n (%)

 

 Hypertension

6 (28.6)

 Diabetes mellitus

6 (28.6)

 Coronary heart disease

1 (4.8)

Symptom and sign, n (%)

 

 Dysphagia

14 (66.7)

 Choking cough

2 (9.5)

 Others

5 (23.8)

Location of carcinoma

 

 Upper middle segment

9 (42.9)

 Meddle lower

4 (19.0)

 Esophageal cardia junction

7 (33.3)